Constructing bilayer and volumetric atrial models at scale.
Caroline H RoneyJosé Alonso Solís-LemusCarlos Lopez BarreraAlexander ZolotarevOnur UlgenEric KerfootLaura BevisSemhar MisghinaCaterina Vidal HorrachOvais A JafferyMahmoud EhneshDhani DharmapraniGonzalo Ricardo Ríos-MuñozAnand GanesanWilson W GoodAurel NeicNagaiah ChamakuriLuuk H G A HopmanMarco J W GötteShohreh HonarbakhshSanjiv M NarayanEdward J VigmondSteven A NiedererPublished in: Interface focus (2023)
To enable large in silico trials and personalized model predictions on clinical timescales, it is imperative that models can be constructed quickly and reproducibly. First, we aimed to overcome the challenges of constructing cardiac models at scale through developing a robust, open-source pipeline for bilayer and volumetric atrial models. Second, we aimed to investigate the effects of fibres, fibrosis and model representation on fibrillatory dynamics. To construct bilayer and volumetric models, we extended our previously developed coordinate system to incorporate transmurality, atrial regions and fibres (rule-based or data driven diffusion tensor magnetic resonance imaging (MRI)). We created a cohort of 1000 biatrial bilayer and volumetric models derived from computed tomography (CT) data, as well as models from MRI, and electroanatomical mapping. Fibrillatory dynamics diverged between bilayer and volumetric simulations across the CT cohort (correlation coefficient for phase singularity maps: left atrial (LA) 0.27 ± 0.19, right atrial (RA) 0.41 ± 0.14). Adding fibrotic remodelling stabilized re-entries and reduced the impact of model type (LA: 0.52 ± 0.20, RA: 0.36 ± 0.18). The choice of fibre field has a small effect on paced activation data (less than 12 ms), but a larger effect on fibrillatory dynamics. Overall, we developed an open-source user-friendly pipeline for generating atrial models from imaging or electroanatomical mapping data enabling in silico clinical trials at scale (https://github.com/pcmlab/atrialmtk).
Keyphrases
- left atrial
- magnetic resonance imaging
- computed tomography
- atrial fibrillation
- contrast enhanced
- clinical trial
- high resolution
- left ventricular
- rheumatoid arthritis
- mitral valve
- electronic health record
- mass spectrometry
- big data
- image quality
- randomized controlled trial
- diffusion weighted imaging
- multiple sclerosis
- molecular docking
- systemic sclerosis
- machine learning
- photodynamic therapy
- dual energy
- decision making
- phase ii
- fluorescence imaging